Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.

Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, Olson A, Arribas JR, Moreno S, Meyer L, Del Romero J, Dabis F, Bucher HC, Wandeler G, Vourli G, Skoutelis A, Lanoy E, Gasnault J, Costagliola D, HernĂ¡n MA; HIV-CAUSAL Collaboration.

Neurology. 2014 Jul 8;83(2):134-41. doi: 10.1212/WNL.0000000000000564. Epub 2014 Jun 6.

PMID:
24907236
[PubMed - in process]
2.

Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.

Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, Koutsounas S, Vafiadis I, Nikolopoulou G, Giannoulis G, Germanidis G, Papatheodoridis G, Touloumi G.

J Hepatol. 2013 Nov;59(5):949-56. doi: 10.1016/j.jhep.2013.07.005. Epub 2013 Jul 10.

PMID:
23850875
[PubMed - in process]
3.

Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.

Paraskevis D, Touloumi G, Bakoyannis G, Paparizos V, Lazanas M, Gargalianos P, Chryssos G, Antoniadou A, Psichogiou M, Panos G, Katsarou O, Sambatakou H, Kordossis T, Hatzakis A; AMACS.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):461-9. doi: 10.1089/AID.2012.0143. Epub 2012 Nov 6.

PMID:
23034083
[PubMed - indexed for MEDLINE]
4.
5.

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

HIV-CAUSAL Collaboration.

Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28.

PMID:
22460971
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.

Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK; HEPNET. Greece Cohort Study Group.

Gut. 2011 Aug;60(8):1109-16. doi: 10.1136/gut.2010.221846. Epub 2011 Jan 26.

PMID:
21270118
[PubMed - indexed for MEDLINE]
7.

Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.

Kalofonos HP, Papakostas P, Makatsoris T, Papamichael D, Vourli G, Xanthakis I, Aravantinos G, Papadimitriou C, Pentheroudakis G, Varthalitis I, Samelis G, Syrigos KN, Xiros N, Stavropoulos M, Kosmidis P, Christodoulou C, Linardou H, Skondra M, Pectasides D, Economopoulos T, Fountzilas G.

Anticancer Res. 2010 Oct;30(10):4325-33.

PMID:
21036759
[PubMed - indexed for MEDLINE]
8.

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer.

Bamias A, Karina M, Papakostas P, Kostopoulos I, Bobos M, Vourli G, Samantas E, Christodoulou Ch, Pentheroudakis G, Pectasides D, Dimopoulos MA, Fountzilas G.

Cancer Chemother Pharmacol. 2010 May;65(6):1009-21. doi: 10.1007/s00280-010-1256-6. Epub 2010 Feb 4.

PMID:
20130877
[PubMed - indexed for MEDLINE]
9.

Evaluation of the antioxidant effect of a new functional food enriched with Sideritis euboea in healthy subjects.

Skouroliakou M, Kastanidou O, Stathopoulou M, Vourli G.

J Med Food. 2009 Oct;12(5):1105-10. doi: 10.1089/jmf.2008.0172.

PMID:
19857076
[PubMed - indexed for MEDLINE]
10.

Clinicopathological features of primary fallopian tube carcinoma: a single institution experience.

Papadimitriou CA, Markaki S, Lianos E, Peitsidis P, Vourli G, Nikitas N, Vlachos G, Rodolakis A, Antsaklis A, Dimopoulos MA.

Eur J Gynaecol Oncol. 2009;30(4):389-95.

PMID:
19761129
[PubMed - indexed for MEDLINE]
11.

Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.

Mountzios G, Dimopoulos MA, Bamias A, Vourli G, Kalofonos H, Aravantinos G, Fountzilas G, Papadimitriou CA.

Ann Oncol. 2009 Aug;20(8):1362-8. doi: 10.1093/annonc/mdn797. Epub 2009 May 20.

PMID:
19457937
[PubMed - indexed for MEDLINE]
Free Article
12.

Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.

Pectasides D, Dafni U, Bafaloukos D, Skarlos D, Polyzos A, Tsoutsos D, Kalofonos H, Fountzilas G, Panagiotou P, Kokkalis G, Papadopoulos O, Castana O, Papadopoulos S, Stavrinidis E, Vourli G, Ioannovich J, Gogas H.

J Clin Oncol. 2009 Feb 20;27(6):939-44. doi: 10.1200/JCO.2008.16.3121. Epub 2009 Jan 12.

PMID:
19139440
[PubMed - indexed for MEDLINE]
13.

Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.

Koutras AK, Fountzilas G, Dafni U, Dimopoulos MA, Pectasides D, Klouvas G, Papakostas P, Kosmidis P, Samantas E, Gogas H, Briasoulis E, Vourli G, Petsas T, Xiros N, Kalofonos HP; Hellenic Cooperative Oncology Group.

Anticancer Res. 2008 Sep-Oct;28(5B):2913-20.

PMID:
19031934
[PubMed - indexed for MEDLINE]
Free Article
14.

A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.

Kalofonos HP, Bamias A, Koutras A, Papakostas P, Basdanis G, Samantas E, Karina M, Misailidou D, Pisanidis N, Pentheroudakis G, Economopoulos T, Papadimitriou C, Skarlos DV, Pectasides D, Stavropoulos M, Bafaloukos D, Kardamakis D, Karanikiotis C, Vourli G, Fountzilas G; Hellenic Cooperative Oncology Group Study.

Eur J Cancer. 2008 Aug;44(12):1693-700. doi: 10.1016/j.ejca.2008.05.025. Epub 2008 Jul 17.

PMID:
18639450
[PubMed - indexed for MEDLINE]
15.

Phase II study of irinotecan plus leucovorin and bolus 5-fluorouracil as first- or second-line chemotherapy in patients with advanced gastric or esophageal-gastric junction adenocarcinoma.

Koutras AK, Gerolymos MK, Kontogeorgou E, Iconomou G, Vourli G, Tsiata E, Makatsoris T, Chrysanthopoulos C, Kalofonos HP.

J Chemother. 2007 Dec;19(6):724-30.

PMID:
18230557
[PubMed - indexed for MEDLINE]
16.

Elevation of serum N-terminal pro-brain natriuretic peptide after exercise is an index of myocardial damage or a cytoprotective reflection?

Faviou E, Zachari A, Nounopoulos C, Agrafiotis E, Vourli G, Dionyssiou-Asteriou A.

J Sports Med Phys Fitness. 2008 Mar;48(1):90-6.

PMID:
18212715
[PubMed - indexed for MEDLINE]
17.

Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.

Dimitrakakis C, Keramopoulos D, Vourli G, Gaki V, Bredakis N, Keramopoulos A.

Climacteric. 2005 Dec;8(4):342-51.

PMID:
16390769
[PubMed - indexed for MEDLINE]
18.

Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.

Faviou E, Vourli G, Nounopoulos C, Zachari A, Dionyssiou-Asteriou A.

Free Radic Res. 2005 Apr;39(4):419-29.

PMID:
16028367
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk